- Palabras clave > active pharmacovigilance surveillance
- Palabras clave > adverse drug reactions (ADRs)
- Palabras clave > adverse drug reactions monitoring
- Palabras clave > adverse event (AE)
- Palabras clave > efficacy and safety of medicines
- Palabras clave > Multidrug-resistant Tuberculosis (MDR-TB)
- Palabras clave > national reporting systems - adverse reactions to medicines
- Palabras clave > pharmacovigilance
- Palabras clave > pharmacovigilance - capacity building
- Palabras clave > pharmacovigilance reporting system
(2015; 67 pages)
Kwiecien, A., G. David, and S. R. Ahmad. 2015. Implementing Active Pharmacovigilance and Cohort Event Monitoring for Multidrug-Resistant Tuberculosis Regimens in the Philippines. Submitted to the US Agency for International Development by the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program. Arlington, VA: Management Sciences for Health.
The Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program is a five- year cooperative agreement funded by the United States Agency for International Development (USAID) and implemented by Management Sciences for Health (MSH). The goal of SIAPS is to improve the availability of quality pharmaceutical products and effective pharmaceutical services through strengthening pharmaceutical systems.
In the Philippines, SIAPS supports the Philippines Department of Health (DOH) initiatives to reduce the TB disease burden through a systems approach to strengthening pharmaceutical management and services. SIAPS works with the National TB Program (NTP), National TB Reference Laboratory (NTRL), Food and Drug Administration (FDA), and other partners to build their capacity in pharmaceutical management.
As part of this support, USAID Philippines requested the technical assistance and services of SIAPS to conduct a pharmacovigilance (PV) workshop and provide technical assistance to the NTP and the FDA to strengthen their PV system.